Asthma-related microbes

From WikiMD's WELLNESSPEDIA

Asthma is a chronic inflammatory disease of the airways characterized by variable and recurring symptoms, airflow obstruction, and bronchospasm. Recent studies have suggested that certain microbes may play a role in the development and exacerbation of asthma. This article explores the relationship between asthma and specific microbes, including Chlamydia pneumoniae, Mycoplasma pneumoniae, and Human rhinovirus.

Chlamydia pneumoniae[edit]

Chlamydia pneumoniae

Chlamydia pneumoniae is a species of bacteria that can cause respiratory tract infections. It has been implicated in the exacerbation of asthma symptoms. The bacterium is known to infect the epithelial cells of the respiratory tract, leading to inflammation and potentially worsening asthma control. Studies have shown that patients with asthma may have a higher prevalence of C. pneumoniae infection compared to non-asthmatic individuals.

Mycoplasma pneumoniae[edit]

Mycoplasma pneumoniae is a type of bacteria that lacks a cell wall and is known to cause atypical pneumonia. It has also been associated with asthma exacerbations. M. pneumoniae can trigger immune responses that lead to increased airway inflammation and hyperreactivity, which are hallmarks of asthma. The presence of M. pneumoniae in the respiratory tract of asthmatic patients may contribute to the severity and frequency of asthma attacks.

Human rhinovirus[edit]

Human rhinovirus is a common viral infectious agent that causes the common cold. It is one of the most frequent triggers of asthma exacerbations, especially in children. The virus infects the upper respiratory tract and can lead to increased airway inflammation and obstruction in asthmatic individuals. Rhinovirus infections are associated with increased morbidity in asthma patients, and managing these infections is crucial for controlling asthma symptoms.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.